Heavy-ion therapy enables targeted treatment with minimal impact on healthy tissue and reduced risk of secondary cancers
Toshiba will be delisted on Wednesday after 74 years on the Tokyo exchange, following a decade of upheaval and scandal
Two years ago, it sold an 80.1 per cent stake in its PC business to Sharp